Top Markets
Coin of the day
Atrion Corporation Atrion Corporation

Atrion Corporation

ATRI
Classement en actions #38752
Atrion Corporation, along with its affiliated entities, specializes in the... Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Prix de l'action
$0.45992
Dernière synchronisation: 2024-08-30
Capitalisation boursière
$821.42K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Atrion Corporation (ATRI)

Catégorie

Ratio P/E pour Atrion Corporation (ATRI)
Ratio P/E au August 2026 TTM : 41.74
Selon les derniers rapports financiers et le cours de l'action de Atrion Corporation, le ratio P/E actuel (TTM) est de 41.74. À la fin de l’année 2022, le P/E de l’entreprise était de 28.56.
Historique du ratio P/E pour Atrion Corporation de 2000 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) 41.74 21.46%
2023 34.36 20.33%
2022 28.56 -26.18%
2021 38.68 5.36%
2020 36.72 -3.18%
2019 37.92 -5.40%
2018 40.09 26.02%
2017 31.81 -5.16%
2016 33.54 37.87%
2015 24.33 1.62%
2014 23.94 6.87%
2013 22.40 33.96%
2012 16.72 -10.23%
2011 18.63 7.77%
2010 17.28 -5.53%
2009 18.30 50.54%
2008 12.15 -27.83%
2007 16.84 25.99%
2006 13.37 -3.87%
2005 13.90 13.98%
2004 12.20 -17.96%
2002 14.87 87.49%
2001 7.93 -26.66%
2000 10.81 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
39.92 -4.34%
US
30.38 -27.21%
FR
- -
JP
41.93 0.47%
US
- -
CH
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.